Coordinated Expression of Ets-1, pERK1/2, and VEGF in Retina of Streptozotocin-Induced Diabetic Rats
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Purpose: To investigate the role played by E26 transformation-specific-1 (Ets-1), a transcription factor, and extracellular signal-regulated kinase 1/2 (ERK1/2) in the expression of vascular endothelial growth factor (VEGF), and the interaction of Ets-1 and ERK1/2 in the retina of diabetic rats. Methods: Diabetes was induced in rats by an intraperitoneal injection of streptozotocin (STZ). To follow the time course in the expression of Ets-1, phosphorylated ERK1/2 (pERK1/2), and VEGF, rats were killed at 1, 2, 4, and 8 weeks after the injection of STZ, and total proteins were extracted from the isolated retinas. An adenovirus vector encoding dominant-negative Ets-1 and an inhibitor of PD98059 was injected intravitreally to investigate the effects of Ets-1 blockade and ERK1/2 inhibition on the expression of VEGF. Four weeks after the first intravitreal injection, total proteins and total RNA were extracted from the retinas for Western blot and Northern blot analyses. Results: The expression of Ets-1, pERK1/2, and VEGF in the retina increased in a time-dependent manner after STZ injection. The phosphorylation of ERK1/2 and protein level of VEGF were significantly reduced following intravitreal Ets-1. Inhibition of ERK1/2 phosphorylation resulted in a significant reduction in the expression of Ets-1 and the level of VEGF protein. Conclusions: These results indicate that in the retina of STZ-induced diabetic rats: (1) the alterations of Ets-1, pERK1/2, and VEGF are approximately synchronized; (2) the phosphorylation of ERK1/2 is regulated by the expression of Ets-1; (3) the production of Ets-1 protein is dependent on the ERK1/2 pathway, and (4) the protein level of VEGF is regulated by both Ets-1 expression and ERK1/2 phosphorylation. We propose that VEGF, Ets-1, and ERK1/2 act synergistically in the development of diabetic retinopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings have been corroborated by other studies that show that in the retina of STZ-induced diabetic rats, pERK1/2 and VEGF are approximately synchronized, and that the protein level of VEGF is regulated by ERK1/2 phosphorylation.”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [79]
In the citing paper
“These data suggest that VEGF, Ets-1, and ERK1 act synergistically in the development of DR [ 79 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [79]
Citations
Cites
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986 · cited 1×
“However, our results showed that the inhibition of ERK1/2 pathway did not fully abolish the increase in VEGF, suggesting that other intracellular signaling pathways could also be involved in mediating the expression of VEGF in the diabetic retina.It has been proven that VEGF exerts its effects by binding to its two hi…”
ResultVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617 · cited 1×
“Therefore, extrapolating these studies and our results, we propose that VEGF, Ets-1, and ERK1/2 may act synergistically in the pathological development of diabetic retinopathy with the involvement of both Flt-1 and Flk-1. Our postulation can be summarized as follows (fig. 4 ). First, STZ-induced hyperglycemia results…”
ResultAiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 1×
“Ets-1 is a prototype of the ETS family of transcription factors which are characterized by a conserved ETS domain that is capable of binding to DNA sequences containing a core GGAA/T motif [”
BackgroundAntonetti, D. A., Barber, A. J., Khin, S., Lieth, E., Tarbell, J. M., & Gardner, T. W. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1953 · Cited by 577
Ets transcription factors: nuclear effectors of the Ras–MAP-kinase signaling pathway
Wasylyk, B., Hagman, J., & Gutierrez-Hartmann, A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01211-0 · Cited by 504
Guo, D., Jia, Q., Song, H.-Y., Warren, R. S., & Donner, D. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6729 · Cited by 482
Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., & Shibuya, M. (1995) · PubMed · Cited by 464
Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H. S., Zack, D. J., Ettyreddy, D., et al. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1114 · Cited by 337
Iwasaka, C., Tanaka, K., Abe, M., & Sato, Y. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199612)169:3<522::aid-jcp12>3.0.co;2-7 · Cited by 278
Wernert, N., Raes, M., Lassalle, P., Dehouck, M., Gosselin, B. J., Vandenbunder, B., & Stéhelin, D. (1992) · PubMed Central · Cited by 231
Hammes, H. P., Lin, J., Bretzel, R. G., Brownlee, M., & Breier, G. (1998) · Diabetes · doi:10.2337/diabetes.47.3.401 · Cited by 222 · cited 1×
“and an increased VEGF expression is accompanied by an upregulation of Flt-1 and Flk-1 in experimental diabetic retinopathy [”
BackgroundOda, N., Abe, M., & Sato, Y. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199902)178:2<121::aid-jcp1>3.0.co;2-f · Cited by 211
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
Zhan, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24403 · Cited by 209
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191 · cited 1×
“It has been demonstrated that the expression of the mRNA of VEGF is induced through an extracellular signal-regulated kinase (ERK)-dependent pathway in cultured human retinal pigment epithelial cells (ARPE-19) [”
BackgroundAn ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors
Seidel, J. J., & Graves, B. J. (2002) · Genes & Development · doi:10.1101/gad.950902 · Cited by 182 · cited 1×
“Our results also showed that ERK1/2 phosphorylation was significantly inhibited by Ets-1 blockade in the diabetic rat retina. Although the mechanism of how ERK1/2 phosphorylation is regulated by Ets-1 is not well understood, previous studies have demonstrated that Ets-1 contains an ERK-docking site which can bind dire…”
BackgroundThe Ets family contains transcriptional activators and repressors involved in angiogenesis
Lelièvre, E., Lionneton, F., Soncin, F., & Vandenbunder, B. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00025-5 · Cited by 178
CCL2 Regulates Angiogenesis via Activation of Ets-1 Transcription Factor
Stamatovic, S. M., Keep, R. F., Mostarica-Stojkovic, M., & Andjelkovic, A. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2651 · Cited by 177
Park, K., Luo, J.-M., Hisheh, S., Harvey, A. R., & Cui, Q. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3532-04.2004 · Cited by 166 · cited 1×
“In brief, 1 μl containing 1× 10 10 plaque-forming units/ml of the adenovirus vector encoding dominant-negative Ets-1 was injected into the vitreous of anesthetized rats with a 33-gauge needle (Ito, Hamamatsu, Japan). For control, an equivalent amount of null adenovirus was injected into the contralateral eye. All rats…”
MethodGoetze, S., Kintscher, U., Kaneshiro, K., Meehan, W. P., Collins, A., Fleck, E., Hsueh, W. A., & Law, R. E. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00497-x · Cited by 133 · cited 1×
“We thus propose that Ets-1 regulates ERK1/2 phosphorylation through the ERK-docking site in the diabetic rat retina.We also demonstrated that 4 weeks after an intraocular injection of PD98059, the Ets-1 protein level was significantly reduced in comparison to that in control eyes. This suggests that the expression of…”
ResultRole of ETS Family Transcription Factors in Vascular Development and Angiogenesis.
Sato, Y. (2001) · Cell Structure and Function · doi:10.1247/csf.26.19 · Cited by 131
High Glucose Induced VEGF Expression via PKC and ERK in Glomerular Podocytes
Hoshi, S., Nomoto, K.-I., Kuromitsu, J., Tomari, S., & Nagata, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6138 · Cited by 122 · cited 1×
“In addition, mouse podocyte cells cultured with high glucose show a significant increase in ERK1/2 activity, and high glucose-induced VEGF mRNA and protein expression can be abolished by PD98059 [”
BackgroundIn Vivo Evidence of Angiogenesis Induced by Transcription Factor Ets-1
Hashiya, N., Jo, N., Aoki, M., Matsumoto, K., Nakamura, T., Sato, Y., Ogata, N., Ogihara, T., Kaneda, Y., & Morishita, R. (2004) · Circulation · doi:10.1161/01.cir.0000130643.41587.db · Cited by 106
Valter, M. M., Hügel, A., Huang, H. J., Cavenee, W. K., Wiestler, O. D., Pietsch, T., & Wernert, N. (1999) · PubMed · Cited by 94
Lelièvre, E., Mattot, V., Huber, P., Vandenbunder, B., & Soncin, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203563 · Cited by 92
Ojima, T., Takagi, H., Suzuma, K., Oh, H., Suzuma, I., Ohashi, H., Watanabe, D., Suganami, E., Murakami, T., Kurimoto, M., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050435 · Cited by 82 · cited 1×
“Inhibition of the phosphorylation of ERK1/2 resulted in both a reduction of VEGF-induced angiogenesis in cultured bovine retinal endothelial cells (BRECs) and an inhibition of VEGF-related vasopermeability in a mouse model of retinopathy of prematurity [”
BackgroundWatanabe, D., Takagi, H., Suzuma, K., Suzuma, I., Oh, H., Ohashi, H., Kemmochi, S., Uemura, A., Ojima, T., Suganami, E., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63741-8 · Cited by 75
Neely, K. A., & Gardner, T. W. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65607-6 · Cited by 62
Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori, K., Gehlbach, P. L., Ando, A., Wahlin, K. J., Gunther, V., McVey, D., Wei, L. L., & Campochiaro, P. A. (2002) · PubMed · Cited by 47
Grewal, S., Molina, D. M., & Bardwell, L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.001 · Cited by 47
Glyn-Jones, S., Song, S., Black, M. A., Phillips, A. R. J., Choong, S. Y., & Cooper, G. J. S. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00204.2006 · Cited by 47
Yu, X., Li, C., Wang, K.-Y., & Dai, H.-Y. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.07.001 · Cited by 44 · cited 1×
“We also examined the role played by ERK1/2 phosphorylation in the expression of VEGF in the same animal model and found that VEGF expression was reduced significantly by an intraocular injection of PD98059. Our results agree with previous findings that during the pathogenic process of psoriasis, an increase in VEGF ex…”
ResultNakabayashi, M., Morishita, R., Nakagami, H., Kuba, K., Matsumoto, K., Nakamura, T., Tano, Y., & Kaneda, Y. (2003) · Diabetologia · doi:10.1007/s00125-002-0954-y · Cited by 43 · cited 1×
“The VEGF-induced angiogenesis can be inhibited by either the expression of Ets-1 or the phosphorylation of ERK1/2 in both cultured human aortic endothelial cells and in a rabbit corneal neovascularization model [”
BackgroundSelf-citationTeruyama, K., Abé, M., Nakano, T., Takahashi, S., Yamada, S., & Sato, Y. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02724-7 · Cited by 33
Transcription factor ETS-1 as a molecular target for angiogenesis inhibition.
Sato, Y. (1998) · PubMed · Cited by 31
Díaz-Rodríguez, E., Piñeiro, A., Casanueva, F. F., & Camiña, J. P. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.016 · Cited by 7
Research works printed but not linked: 1
- 10.1016%2fs0021-9150%2801%2900497-x · DOI
Cited by
Quantitative Genetics of Food Intake in Drosophila melanogaster
Garlapow, M. E., Huang, W., Yarboro, M. T., Peterson, K. R., & Mackay, T. F. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138129 · Cited by 131
“The mammalian orthologs are increased in the serum of obese humans [146], correlate with adipose tissue generation [147], increase obesity-related adipose tissue inflammation [148], are upregulated in diabetes [149], act in the development of diabetic retinopathy [150] and nephropathy [151], and reduce endothelial pro…”
BackgroundMAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“These data suggest that VEGF, Ets-1, and ERK1 act synergistically in the development of DR [79].”
BackgroundGong, C., Lü, B., Hu, Q., & Ji, L. (2013) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2013.05.03 · Cited by 48
Diffley, J. M., Wu, M., Sohn, M., Song, W., Hammad, S. M., & Lyons, T. J. (2009) · PubMed Central · Cited by 35
Huang, J., Li, X., Li, M., Li, S., Xiao, W., Chen, X., Cai, M., Wu, Q., Luo, H., Tang, S., et al. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01584.x · Cited by 33
“After STZ injection, the expression of VEGF in the retina of diabetic rats is significantly increased at 2 weeks and keeps on being increased in a timedependent manner within 8 weeks [28,29].”
Background
Metadata
- Authors
- Du, Z.-J., Kamei, M., Suzuki, M., Tano, Y., Wang, B.-R., & Hui, Y.-N.
- Affiliations
- Xijing Hospital (CN)
- The University of Osaka (JP)
- Air Force Medical University (CN)
- Venue
- Ophthalmic Research
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 39
- Issue
- 4
- Pages
- 224-231
- ISSN
- 0030-3747 (ISSN-L)
- 1423-0259
- OpenAlex
- W2061464417
- Cited by
- 12
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 2 · 2017: 2 · 2015: 1 · 2012: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Ophthalmic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- ETS1, ERK1/2 phosphorylation, vascular endothelial growth factor, diabetic retinopathy, streptozotocin-induced diabetes, retina, transcription factor regulation, ERK signaling, PD98059, intravitreal gene delivery
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Female, Phosphorylation, Retina, Time Factors, Rats, Sprague-Dawley, Mitogen-Activated Protein Kinase 1, Vascular Endothelial Growth Factor A, Extracellular Signal-Regulated MAP Kinases, Mitogen-Activated Protein Kinase 3, Proto-Oncogene Protein c-ets-1, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.